Work

Mo1872 - Adalimumab Persistence at 1 Year is Significantly Higher in an Integrated Health Care System than for Privately Insured Patients with Inflammatory Bowel Disease

Year: 2018

Type: conference-abstract

Source: Gastroenterology

DOI: 10.1016/s0016-5085(18)32836-1

Authors: Shail M. Govani, Rachel Lipson, Mohamed Noureldin, Wyndy L. Wiitala, Peter D. Higgins, Jacqueline A. Pugh, Dawn I. Velligan, Ryan W. Stidham, Akbar K. Waljee

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2803007011

Cites:

Cited by:

Related to: 10